Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cell density, Her2 and progesterone signaling regulate dissemination of breast cancer cells

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus

PROVIDER: GSE68683 | GEO | 2016/12/08

SECONDARY ACCESSION(S): PRJNA283387

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Cell density, Her2 and progesterone signaling regulate dissemination of breast cancer cells [Gene expression]

Project description:Disseminated breast cancer cells display genotypes disparate from the predominant clone of the primary tumor before manifestation of metastasis, suggesting that cancer cell dissemination occurs preferentially early; however, the underlying molecular mechanisms are unknown. Investigating metastasis in a Her2-driven mouse model, we found that the progesterone-induced paracrine cytokines Wnt4 and Rankl induced migration and early dissemination shortly after Her2 activation. Once tumorigenic growth was established, progesterone receptor (PgR) expression was lost and Wnt4/Rankl induced proliferation. The altered response from migration to proliferation was determined by cell density involving miRNA-regulated PgR expression and was reversible. Cells from early, low-density lesions displayed more functional stemness traits than cells from dense, advanced tumors, migrated more and founded significantly more metastases. The data suggest that many metastases are derived from early-disseminated cancer cells, implying that our concepts for systemic therapy need to be revised.

2016-12-08 | GSE68681 | GEO

Cell density, Her2 and progesterone signaling regulate dissemination of breast cancer cells [miRNA-Seq]

2016-12-08 | GSE68682 | GEO

Cell density, Her2 and progesterone signaling regulate dissemination of breast cancer cells

Project description:Cell density, Her2 and progesterone signaling regulate dissemination of breast cancer cells

| PRJNA283387 | ENA

Hippo signaling regulates Microprocessor and links cell density-dependent miRNA biogenesis to cancer

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2014-03-03 | E-GEOD-52276 | biostudies-arrayexpress

Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-06-01 | E-GEOD-80098 | biostudies-arrayexpress

Divergent resistance mechanisms to HER2-targeted therapies in breast cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-04-21 | GSE161423 | GEO

PI3K/AKT signaling regulates H3K4 methylation in breast cancer

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-06-14 | E-GEOD-80594 | biostudies-arrayexpress

BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling.

Project description:The bromodomain and extraterminal (BET) proteins are epigenetic "readers" of acetylated histones in chromatin and have been identified as promising therapeutic targets in diverse cancers. However, it remains unclear how individual family members participate in cancer progression and small molecule inhibitors such as JQ1 can target functionally independent BET proteins. Here, we report a signaling pathway involving BRD4 and the ligand/receptor pair Jagged1/Notch1 that sustains triple-negative breast cancer migration and invasion. BRD4, but not BRD2 or BRD3, regulated Jagged1 expression and Notch1 signaling. BRD4-selective knockdown suppressed Notch1 activity and impeded breast cancer migration and invasion. BRD4 was required for IL6-stimulated, Notch1-induced migration and invasion, coupling microenvironment inflammation with cancer propagation. Moreover, in patients, BRD4 and Jagged1 expression positively correlated with the presence of distant metastases. These results identify a BRD4/Jagged1/Notch1 signaling pathway that is critical for dissemination of triple-negative breast cancer. Cancer Res; 76(22); 6555-67. ©2016 AACR.

| S-EPMC5290198 | biostudies-literature

Drug screening and genomic analyses of HER2 positive breast cancer cell lines reveal predictors for treatment response

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-01-30 | E-GEOD-58887 | biostudies-arrayexpress

Adaptive responses to HER2-directed therapy in breast cancer cell line models

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-11-03 | GSE160670 | GEO